Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course

Rachel E. Harris, Marina Aloi, Lissy De Ridder*, Nicholas M. Croft, Sibylle Koletzko, Arie Levine, Dan Turner, Gigi Veereman, Mattias Neyt, Laetitia Bigot, Frank M. Ruemmele, Richard K. Russell

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course'. Together they form a unique fingerprint.

Medicine & Life Sciences